Friday, August 24, 2018

Investorideas.com - #Cannabisstocks: Organigram (TSXV: $OGI.V) (OTCQB: $OGRMF) signs supply agreement with Nova Scotia Liquor Corporation

Investorideas.com - #Cannabisstocks: Organigram (TSXV: $OGI.V) (OTCQB: $OGRMF) signs supply agreement with Nova Scotia Liquor Corporation

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabis Distribution Association Commends #California Legislature on Passage of SB 311

Investorideas.com - #Cannabis Distribution Association Commends #California Legislature on Passage of SB 311

Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance trading Ep20: #cannabisstocks #trading #ETFs #sweepstakes #goodtrading

Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance trading Ep20: #cannabisstocks #trading #ETFs #sweepstakes #goodtrading





Good #Trading with #Stock Analyst Guru
Richard Lazarow- Support and Resistance Trading Ep20: #cannabisstocks
trading #ETFs #sweepstakes #goodtrading

Learn
how to trade like a Wall Street Analyst

New York, NY, Delta BC – New York, NY,
Delta BC – August 24, 2018 – Investorideas.com (
www.investorideas.com), a global news source
covering leading sectors issues today’s episode of its educational trading
podcast featuring the founder of Stock Analyst Guru, LLC, Richard Lazarow.

Episode
20: Support and Resistance #trading: #cannabisstocks
#trading #ETFs #sweepstakes #goodtrading  

Hear
the podcast:

About
the podcast
: Investorideas.com exclusive podcast
series with the founder of Stock Analyst Guru, Richard Lazarow.


Richard has over 10 years of institutional
equity experience as a stock analyst / portfolio manager and stock trader,
managing stock positions at Hedge Funds and other Funds in NYC. In this weekly
podcast series you will hear his insights on
learning how to invest based on the most important aspects of investing,
identifying Support & Resistance, and Trend.  These top-down Market updates
and sector close-ups are extremely useful in helping to keep investors more
fully invested in stocks and in the correct sectors ONLY while the Market and a
stock’s Sector are healthy (i.e. going UP), and are just a small part of his
valuable training. For the full educational experience you can check out
www.stockanalystguru.com.

Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.


Stock Analyst Guru is offering a Sweepstakes to all
Investor Ideas members, subscribers, and friends.  Just sign up for the FREE Fundamental Curriculum
(no CC needed) and that enters you into the drawing, with 1st prize being a
discount code for $2900 OFF of our entire Curriculum, bringing the final price
to ONLY $97, which is about 97% off!
Second place will be a discount code for $2700 off
(final price: $297), and 3rd-5th places a code for $2500 off (final price:
$497)! 



Stock Analyst Guru,
LLC - Richard Lazarow

Learn how to trade like a Wall Street
Analyst: Download Stock Analyst Guru’s  free trading curriculum and be
automatically entered into the sweepstakes

To help you follow and track sectors
Investorideas.com has created stock directories of publicly traded stocks for
investors to use as a research tool to start trading and investing.
Visit http://www.investorideas.com/membership/  to learn more about our stock directories in
leading sectors  

About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and  sector trends 
from Investorideas.com with our news alerts , articles ,
podcasts
and videos  talking about cannabis,  crypto, 
technology including  AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily
Crypto Corner
and Podcast,
Play
by Play
sports and stock news column, Investor Ideas
#Potcasts
#Cannabis News and Stocks on the Move podcast and
column,  Cleantech and Climate Change
Podcast and  the Stock Guru daily podcast
on Support and Resistance Trading.

The
Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio
and Google Play Music.

Visit the Podcast page at
Investorideas.com:
http://www.investorideas.com/Audio/

Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, contents creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Additional info regarding BC Residents and
global Investors: Effective September 15 2008 - all BC investors should review
all OTC and Pink sheet listed companies for adherence in new disclosure filings
and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations
of each country.

Please read Investorideas.com privacy
policy:
http://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social
media services at Investorideas.com


To
learn more about the Investorideas.com podcast series or to sponsor a podcast:

Contact Investorideas.com
800-665-0411



Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSXV: $N.V, TSXV: $OGI.V, CSE: $MYM.C


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSXV: $N.V,  TSXV: $OGI.V, CSE: $MYM.C


Delta, Kelowna, BC –August 24, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Namaste Technologies Inc. trading on the TSX-Venture as N, Organigram Holdings Inc. trading on the TSX-Venture as OGI and the OTCQB as OGRMF and MYM Nutraceuticals Inc., trading on the CSE as MYM.

Namaste Technologies Inc. announced that the Company has received official approval of the latest version of its NamasteMD cannabis telemedicine App for Google Android devices, which is live in the Google Play store as of 8 AM EST August 23rd, 2018. Approximately 50% of mobile phone users in Canada use Android devices. With the new launch of the apps on both iOS and Android platforms, NamasteMD can now facilitate online patient consultations, free of charge, within 15 minutes from sign-up on the App. The Company anticipates launching real-time consultations through NamasteMD within the next 10 days. Further to the Company's Aug 22nd news release, NamasteMD has achieved over 14,000 registered users, representing a 130% increase over a 2-month period. The Company anticipates significant acceleration in conversion rates with additional exposure through the Google Play store.
Namaste has developed Canada's first fully-compliant medical cannabis patient portal, available on iPhone or Android devices, which allows Namaste to acquire patients faster and at a lower cost in comparison with other Licensed Producers. Patients acquired through NamasteMD have access to purchase medical cannabis through Namaste's cultivation partners. Under the terms of various Educational Service Agreements, Namaste collects between 15-20% of the gross revenue derived from patient purchasing through referrals to Licensed Producers under NamasteMD. Namaste is presently partnered with over 10 Licensed Producers.  
With Namaste's medical cannabis "sales-only" license imminent, the Company anticipates a sharp increased revenue and margin with Cannmart booking full revenue amounts from patient ordering and the Company will aim to maintain a minimum of a 50% gross margin on cannabis products sold directly on its website.

Organigram Holdings Inc., the parent company of Organigram Inc, a leading licensed producer of medical marijuana, announced that the Company has signed a supply agreement with Nova Scotia Liquor Corporation (NSLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the province.
"We are pleased to announce our supply agreement with NSLC," says Greg Engel, Organigram's Chief Executive Officer. "Our home markets have always been a key priority for Organigram and this announcement solidifies our position as the market leader here in the Maritimes. With supply arrangements in place in six provinces, we take great pride in our place as a national leader working towards a responsible, sustainable and successful adult-use recreational cannabis market."

MYM Nutraceuticals Inc., announced that it has entered into a partnership with the University of Sherbrooke to study the medicinal and industrial uses of cannabis and hemp. Researchers at the University of Sherbrooke will work with an on-site coordinator to create partnerships by targeting expertise in various faculties and training centres.
During cannabis prohibition, research on its compounds and by-products remained very limited. This partnership aims to explore the benefits of the cannabis plant. "Université de Sherbrooke groups together a broad set of skills in relation to the opportunities associated with cannabis," said Vincent Aimez, Vice-President, Commercialization and Partnerships, University of Sherbrooke. "MYM's contribution will help actively explore multiple research projects. This is a completely new and highly promising multidisciplinary partnership we wish to nurture and grow in the coming years."
Avenues of collaboration range from identifying the best alternative energy systems in greenhouses to the effects of cannabinoids on the nervous and immune systems. Research will also include: industrial materials manufacturing, eco materials, hemp fiber biofuels and opportunities created from the by-products of cannabis production.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


Thursday, August 23, 2018

Investorideas.com - #Cannabisstocks: Pure Global Cannabis (TSX.V: PURE; OTC: PRCNF) Provides Update on Growing International Platform

Investorideas.com - #Cannabisstocks: Pure Global Cannabis (TSX.V: PURE; OTC: PRCNF) Provides Update on Growing International Platform

Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $WEED.TO, CSE: $CHOO,C, CSE: $CRZ.C, TSX: $VFF.TO, TSXV: $EMH.V, CSE: $HUGE.C


Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $WEED.TO, CSE: $CHOO,C, CSE: $CRZ.C, TSX: $VFF.TO,  TSXV: $EMH.V, CSE: $HUGE.C



Delta, Kelowna, BC –August 23, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Choom™ (CSE: CHOO & OTCQB:CHOOF),  CannaRoyalty Corp.(CSE: CRZ) , Village Farms International, Inc. (TSX: VFF and  OTC: VFFIF), Emerald Health Therapeutics, Inc. ( TSX-Venture: EMH) , Canopy Growth Corporation (TSX: WEED and  NYSE:CGC ) and FSD Pharma Inc. (CSE: HUGE and OTC: FSDDF).

Choom™ an emerging, fully-integrated cannabis company, announced that it has advanced its retail portfolio and the build-out of its cannabis retail store network in Alberta and British Columbia.
Choom has secured the rights to an additional 5 retail locations in Alberta and 7 in B.C. These new retail opportunities bring Choom's total retail potential up to 52 locations across western Canada. Choom's rapidly expanding provincial presence now stands at 29 leases in highly strategic and secure locations in Alberta with 28 applications submitted, in combination with 17 retail opportunities in B.C.

CannaRoyalty Corp. today announced the Company's financial results for the three and six-month periods ended June 30, 2018.
"Q2 marked a turning point for CannaRoyalty and its shareholders as the team translated strategy and execution into record financial performance. The Company generated earnings per share of $0.18 primarily by delivering on its stated objective of rationalizing early passive investments. The Company also generated a record adjusted EBITDA result for a Canadian-listed cannabis company2," said Marc Lustig, CEO of CannaRoyalty. "Q2 is the beginning of a multi-quarter parabolic step change in revenue, powered by sequential acquisitions and organic growth. CannaRoyalty generated a record $3.5 million in revenue this quarter, a 446% increase from Q1 and more than the Company generated in all of 2017. These results reflect the successful initiation of the Company's strategic focus on building its Californian distribution and brands platform. This growth is expected to continue in Q3 and Q4 as FloraCal and RVR are added to the Company's financials and as our team continues to grow market share and expand the Company's supporting manufacturing and value-add services footprint. Both RVR and FloraCal are performing above expectations, and we are actively executing our plans to increase the revenue generating capacity of both companies. I thank all of our long term shareholders for their faith in this team and our plan. I am proud to say that this is truly just the beginning of the CannaRoyalty story."

Some of the financial results highlights included:

·        Q2-2018 Revenue of $3.5 million compared to $643,437 in Q1-2018 – marks the successful initiation of California distribution and manufacturing strategy.
·        Net income of $9.3 million (EPS of $0.18) and EBITDA of $10.4 million generated through execution of stated strategy to rationalize non-core assets and an increase in gross margin related to growing product sales.
·        FloraCal (closed July 2nd) and RVR Distribution ("RVR") (closing in Q3-2018) are performing above plan and are expected to drive sequential revenue growth through the second half of 2018 and beyond.
·        Premier cannabis brand development platform powered by five licensed distribution and manufacturing facilities across California, delivering several of the state's top independent branded products to the majority of licensed dispensaries in the state.17

Village Farms International, Inc. and Emerald Health Therapeutics, Inctoday announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its third amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area by 195,000 square feet to approximately 420,000 square feet of the 1.1-million square foot Delta 3 production facility. The newly licensed area will be in commercial production this week, as the Delta 3 nursery has been producing cuttings in anticipation of this expansion.

Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted for cannabis production by year end. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms (seven of which are now licensed) optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging.

Canopy Rivers Corporation, the venture capital investment platform of Canopy Growth Corporation, announced that it has set a date of September 12, 2018, for its upcoming shareholder meeting in connection with the proposed business combination involving AIM2 Ventures Inc. and Canopy Rivers.
As previously announced, Canopy Rivers has entered into a definitive amalgamation agreement with AIM2, which outlines the terms and conditions pursuant to which the parties will complete the Go Public Transaction. The Go Public Transaction will result in a reverse take-over of AIM2 by Canopy Rivers and will constitute AIM2's "Qualifying Transaction" under Policy 2.4 – Capital Pool Companies of the TSXV Corporate Finance Manual.
Subject to receipt of all required approvals, including the final approval of the TSX Venture Exchange, the Go Public Transaction is expected to close and the subordinated voting shares of the resulting issuer are expected to commence trading on the TSXV under the symbol "RIV" during the week of September 17, 2018.

FSD Pharma Inc. reported today that its strategic R&D partner, SciCann Therapeutics Inc., has achieved positive results in a pre-clinical efficacy study of its proprietary "Steady Stomach" CBD combination product for Inflammatory Bowel Disease (IBD). Under the terms of the agreement between FSD and SciCann, FSD Pharma holds exclusive marketing and distribution rights for the "Steady Stomach" product in Canada.
The "Steady Stomach" product is a patent-pending combination of Cannabidiol (CBD) together with additional synergistic factors that potentiate and activate the anti-inflammatory properties of CBD, thus making it more effective as a potential treatment for IBD disorders. All active ingredients of the "Steady Stomach" formulation are natural food-grade compounds, thus qualifying it as a CBD food supplement product. Previously completed tox studies in rodents performed by SciCann has demonstrated very high safety profile for the combination product, without any observed adverse events.
The pre-clinical study used a gold standard rodent model of Ulcerative Colitis, and demonstrated a significant 3-fold improved efficacy for the combination product, as compared to CBD alone, in reversing the deleterious effects caused by the colitis induction agent in the study model. Specifically, while the CBD alone arm achieved only a 27% improvement score as compared to the non-treated control arm, the "Steady Stomach" combination treatment arm achieved a 79% improvement score, thus almost completely alleviating the Colitis symptoms induced in the model animals.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the Stock Guru daily podcast on Support and Resistance Trading.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com
800-665-0411




Do you trade or invest in Marijuana / Hemp Stocks?  Check out our stock directory of publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


#Cannabisstocks - Canopy Rivers Updates Upcoming Go Public Transaction; Venture capital investment platform of Canopy Growth (TSX: $WEED. TO) (NYSE: $CGC)


#Cannabisstocks - Canopy Rivers Updates Upcoming Go Public Transaction; Venture capital investment platform of Canopy Growth  (TSX:  $WEED. TO) (NYSE: $CGC)



TORONTO, ON -  August 23, 2018 – (Investorideas.com Newswire) Canopy Rivers Corporation ("Canopy Rivers"), the venture capital investment platform of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth"), is pleased to announce that it has set a date of September 12, 2018, for its upcoming shareholder meeting in connection with the proposed business combination involving AIM2 Ventures Inc. ("AIM2") and Canopy Rivers (the "Go Public Transaction").
   

As previously announced, Canopy Rivers has entered into a definitive amalgamation agreement with AIM2, which outlines the terms and conditions pursuant to which the parties will complete the Go Public Transaction. The Go Public Transaction will result in a reverse take-over of AIM2 by Canopy Rivers and will constitute AIM2's "Qualifying Transaction" under Policy 2.4 – Capital Pool Companies of the TSXV Corporate Finance Manual.

Subject to receipt of all required approvals, including the final approval of the TSX Venture Exchange (the "TSXV"), the Go Public Transaction is expected to close and the subordinated voting shares of the resulting issuer are expected to commence trading on the TSXV under the symbol "RIV" during the week of September 17, 2018.

"With Canopy Rivers, we are well-positioned to take advantage of the universe of investment opportunities unfolding globally in the ever-expanding cannabis economy," said Bruce Linton, Chairman and acting CEO of Canopy Rivers, and co-CEO of Canopy Growth. "The strategic relationship with Canopy Growth, strong management and access to capital will enable Canopy Rivers to build upon a proven track record and continue to develop a leading ecosystem of cannabis companies across the entire cannabis value chain."

To date, Canopy Rivers has made investments in eleven domestic and international companies, establishing a diversified portfolio of licensed producers, late stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms.

As previously announced, subject to the satisfaction of certain escrow release conditions, the net proceeds from Canopy Rivers' $104 million subscription receipt financing are expected to be released from escrow in connection with the closing of the Go Public Transaction. The oversubscribed private placement, which was co-led by CIBC Capital Markets, GMP Securities L.P. and Eight Capital, on behalf of a syndicate of agents including Cormark Securities Inc., INFOR Financial Inc. and PI Financial Corp., closed on July 6, 2018.

About Canopy Rivers:

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED, NYSE:  CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding: the timing for the closing of the Go Public Transaction and the commencement of trading of the subordinated voting shares of the resulting issuer; the timing and anticipated release of the net proceeds from the subscription receipt financing; Canopy Rivers' position and opportunity in the cannabis economy; the ability to build a leading ecosystem of cannabis companies; and the expected benefits to be obtained by Canopy Rivers' portfolio companies. Investors are cautioned that forward-looking information is not based on historical facts but instead reflect Canopy Rivers' management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to consummate the Go Public Transaction; possible termination of the amalgamation agreement; the ability to obtain requisite regulatory and shareholder approvals and the satisfaction of other conditions to the consummation of the Go Public Transaction on the proposed terms and schedule; the potential impact of the announcement or consummation of the Go Public Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; the re-rating potential following the consummation of the Go Public Transaction; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws, including the approval and implementation of the Cannabis Act; compliance with extensive government regulation; and the diversion of management time on the Go Public Transaction. This forward-looking information may be affected by risks and uncertainties in the business of Canopy Rivers and market conditions. 

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

SOURCE Canopy Rivers

For further information: Canopy Rivers Corporation, Daniel Pearlstein, Executive Vice President, Strategy, Canopy Rivers Corporation, daniel@canopyrivers.com, 647-475-1115

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Marijuana / Hemp Stocks
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news